Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 164 publications
Single agent selinexor is active in patients with myelofibrosis refractory or intolerant to JAK inhibitors.
Journal: Blood cancer journal
Published: April 30, 2026
Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera.
Journal: Annals of hematology
Published: December 21, 2025
Do Andean Aymara High-Altitude-Enriched Genetic Variants Protect Europeans Against Acute Mountain Sickness?
Journal: Acta physiologica (Oxford, England)
Published: December 04, 2025
VHL, transferrin, and erythropoietin in the regulation of hepcidin.
Journal: HemaSphere
Published: September 11, 2025
High altitude: A forgotten cause of pulmonary oedema.
Journal: Lung India : official organ of Indian Chest Society
Published: August 20, 2025
Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation.
Journal: American journal of hematology
Published: June 23, 2025
Metformin alleviates side effects and supports the resumption of interferon therapy in polycythemia vera and essential thrombocythemia.
Journal: Haematologica
Published: June 16, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms.
Journal: Current hematologic malignancy reports
Published: June 10, 2025
Last Updated: 09/26/2026